# IOVANCE BIOTHERAPEUTICS, INC. (IOVA) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from IOVANCE BIOTHERAPEUTICS, INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/IOVA/mda/fy2025/): filed 2026-02-24; accession 0001104659-26-018899 (https://www.sec.gov/Archives/edgar/data/1425205/000110465926018899/iova-20251231x10k.htm); latest 10-K
- [FY 2024 MD&A](/company/IOVA/mda/fy2024/): filed 2025-02-27; accession 0001558370-25-001834 (https://www.sec.gov/Archives/edgar/data/1425205/000155837025001834/iova-20241231x10k.htm)
- [FY 2023 MD&A](/company/IOVA/mda/fy2023/): filed 2024-02-28; accession 0001558370-24-002036 (https://www.sec.gov/Archives/edgar/data/1425205/000155837024002036/iova-20231231x10k.htm)
- [FY 2022 MD&A](/company/IOVA/mda/fy2022/): filed 2023-02-28; accession 0001558370-23-002419 (https://www.sec.gov/Archives/edgar/data/1425205/000155837023002419/iova-20221231x10k.htm)
- [FY 2021 MD&A](/company/IOVA/mda/fy2021/): filed 2022-02-24; accession 0001558370-22-001976 (https://www.sec.gov/Archives/edgar/data/1425205/000155837022001976/iova-20211231x10k.htm)

Back to /company/IOVA/